Login
Super Investors STEMPOINT CAPITAL LP
SC

STEMPOINT CAPITAL LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$560M
Positions
91
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (12 quarters reported)

$583M $312M
Q4 23 Q3 24 Q2 25 Q1 26 Q3 26

$375M in Q4 2023 → $560M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
SR Scholar Rock Hldg Corp 5.9% Added 188% 688,954 $33.3M
Erasca Inc 5.9% Added 44% 2,260,594 $33.1M
AS Abivax Sa 4.9% Trimmed 1.5% 279,398 $27.7M
Tango Therapeutics Inc 4.4% Trimmed 19% 989,345 $24.7M
Roivant Sciences Ltd 4.2% Added 84% 641,473 $23.5M
First Tracks Biotherapeutics 4.1% Added 4.4% 649,924 $23M
Enliven Therapeutics Inc 2.7% Trimmed 4.7% 330,476 $15.1M
Alkermes PLC 2.4% Added 34% 333,332 $13.5M
AB Adaptive Biotechnologies Cor 2.4% New 463,551 $13.4M
Dianthus Therapeutics Inc 2.4% Trimmed 25% 150,776 $13.3M
Faeth Therapeutics Inc 2.2% New 404,921 $12M
Spyre Therapeutics Inc 2.1% Added 24% 132,238 $11.8M
IN Immatics N.v 2.1% New 1,308,193 $11.5M
Grail Inc 2.1% New 81,924 $11.5M
PP Praxis Precision Medicines I 2.0% Added 4.0% 38,720 $11.3M
Surrozen Inc 2.0% Trimmed 31% 418,527 $11.1M
C4 Therapeutics Inc 2.0% Added 529% 3,293,376 $11M
Aclaris Therapeutics Inc 1.9% New 2,050,698 $10.8M
Damora Therapeutics Inc 1.9% New 506,067 $10.8M
Revolution Medicines Inc 1.8% Trimmed 69% 50,000 $10.3M
Cytokinetics Inc 1.7% Added 93% 145,760 $9.61M
Beone Medicines Ltd 1.6% New 25,051 $9.17M
Xenon Pharmaceuticals Inc 1.5% Added 192% 222,287 $8.27M
Johnson & Johnson 1.4% New 30,000 $7.94M
Trevi Therapeutics Inc 1.4% New 552,245 $7.91M
Eli Lilly & Co 1.4% New 6,599 $7.64M
AP Arrowhead Pharmaceuticals In 1.3% Added 180% 109,926 $7.19M
Cerus Corp 1.3% New 2,967,942 $7.06M
Immunovant Inc 1.2% Trimmed 27% 201,334 $6.8M
Jade Biosciences Inc 1.2% New 471,718 $6.63M
Guardant Health Inc 1.1% New 33,527 $5.98M
Omniab Inc 1.1% New 1,204,038 $5.97M
Cogent Biosciences Inc 1.1% New 184,173 $5.9M
Biohaven Ltd 0.9% Trimmed 63% 396,865 $5.3M
Mineralys Therapeutics Inc 0.9% Trimmed 67% 200,000 $5.03M
Ideaya Biosciences Inc 0.8% New 123,760 $4.75M
Celcuity Inc 0.8% Trimmed 41% 57,880 $4.6M
Gh Research PLC 0.8% New 195,143 $4.58M
Edgewise Therapeutics Inc 0.8% New 111,577 $4.53M
IN Inflarx Nv 0.8% Trimmed 23% 2,485,233 $4.47M
Century Therapeutics Inc 0.8% Added 19% 2,563,862 $4.38M
Biodesix Inc 0.8% Added 102% 141,548 $4.22M
Biontech Se 0.7% New 42,200 $4.15M
SS Sanofi Sa 0.7% New 99,880 $4.12M
Aura Biosciences Inc 0.7% Trimmed 9.4% 647,406 $4.07M
Cg Oncology Inc 0.7% Trimmed 66% 54,791 $3.88M
NP Newamsterdam Pharma Company 0.7% Added 105% 159,044 $3.87M
KP Kiniksa Pharmaceuticals Intl 0.7% Trimmed 75% 51,804 $3.87M
VT Viridian Therapeutics Inc 0.7% New 187,320 $3.86M
Vor Biopharma Inc 0.7% New 200,836 $3.83M
Lb Pharmaceuticals Inc 0.6% Added 189% 91,757 $3.47M
Edesa Biotech Inc 0.6% New 825,000 $3.47M
AP Avalyn Pharmaceuticals Inc 0.6% Unchanged 118,000 $3.36M
Intuitive Surgical Inc 0.6% New 8,087 $3.29M
Nurix Therapeutics Inc 0.6% New 137,973 $3.27M
Ovid Therapeutics Inc 0.6% Trimmed 47% 1,287,804 $3.21M
Cue Biopharma Inc 0.5% Added 62% 108,647 $2.81M
UT United Therapeutics Corp Del 0.4% New 4,646 $2.52M
Dyne Therapeutics Inc 0.4% New 154,234 $2.48M
AT Attovia Therapeutics Inc 0.4% New 138,200 $2.37M

Showing top 60 of 91 positions.

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
Revolution Medicines Inc Trimmed −109,943 −$22.6M 1.8%
SR Scholar Rock Hldg Corp Added +449,808 +$21.7M 5.9%
Tyra Biosciences Inc Exited −632,754 −$20.2M —
AB Adaptive Biotechnologies Cor New +463,551 +$13.4M 2.4%
Faeth Therapeutics Inc New +404,921 +$12M 2.2%
KP Kiniksa Pharmaceuticals Intl Trimmed −157,430 −$11.7M 0.7%
IN Immatics N.v New +1,308,193 +$11.5M 2.1%
Grail Inc New +81,924 +$11.5M 2.1%
Bioage Labs Inc Exited −464,171 −$11.4M —
Aclaris Therapeutics Inc New +2,050,698 +$10.8M 1.9%

Showing the 10 largest of 129 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
SR Scholar Rock Hldg Corp Trimmed −796,350 −$43.8M 2.3%
Tango Therapeutics Inc Added +1,022,100 +$32M 6.6%
Syndax Pharmaceuticals Inc Exited −1,215,743 −$28.4M —
Erasca Inc Added +1,326,052 +$24.3M 4.9%
Revolution Medicines Inc Trimmed −121,689 −$22.8M 5.2%
Immunovant Inc Trimmed −469,967 −$18.1M 1.8%
Mbx Biosciences Inc Exited −499,469 −$14.9M —
Tyra Biosciences Inc Added +439,577 +$14M 3.5%
KP Kiniksa Pharmaceuticals Intl New +209,234 +$13.4M 2.3%
First Tracks Biotherapeutics New +622,723 +$12.5M 2.2%

Showing the 10 largest of 115 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
Centessa Pharmaceuticals PLC Exited −1,154,114 −$28.9M —
Twist Bioscience Corp Trimmed −475,245 −$22.6M 0.4%
Arcellx Inc Exited −332,860 −$21.7M —
Revolution Medicines Inc Added +219,600 +$21.4M 5.3%
Terns Pharmaceuticals Inc Exited −429,198 −$17.3M —
Roivant Sciences Ltd Trimmed −580,898 −$16.1M 2.1%
Enliven Therapeutics Inc New +363,438 +$14.2M 2.8%
Cg Oncology Inc New +205,622 +$13.9M 2.7%
Biohaven Ltd New +1,594,491 +$13.5M 2.6%
Mbx Biosciences Inc Added +420,916 +$12.6M 2.9%

Showing the 10 largest of 118 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
Roivant Sciences Ltd Trimmed −3,230,489 −$70.1M 3.6%
AS Abivax Sa Added +225,510 +$30.4M 9.1%
Immunovant Inc Trimmed −944,621 −$24M 2.8%
Denali Therapeutics Inc Trimmed −1,315,601 −$21.7M 1.2%
Arcellx Inc Added +321,484 +$21M 3.7%
Twist Bioscience Corp New +518,355 +$16.4M 2.8%
Wave Life Sciences Ltd Exited −2,110,152 −$15.4M —
Structure Therapeutics Inc Added +221,738 +$15.4M 4.2%
Biohaven Ltd Exited −1,017,311 −$15.3M —
Cidara Therapeutics Inc Exited −152,325 −$14.6M —

Showing the 10 largest of 119 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
Roivant Sciences Ltd Added +3,595,406 +$54.4M 12.7%
Madrigal Pharmaceuticals Inc Trimmed −44,487 −$20.4M 0.8%
Mineralys Therapeutics Inc Trimmed −473,474 −$18M 1.2%
Arcellx Inc Trimmed −190,076 −$15.6M 0.2%
Syndax Pharmaceuticals Inc Trimmed −1,006,429 −$15.5M 4.2%
Denali Therapeutics Inc Added +1,026,744 +$14.9M 5.0%
Centessa Pharmaceuticals PLC Trimmed −610,287 −$14.8M 3.2%
Merus N V Exited −266,094 −$14M —
Biohaven Ltd Added +842,557 +$12.6M 3.1%
Cidara Therapeutics Inc Trimmed −114,449 −$11M 2.9%

Showing the 10 largest of 100 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
Roivant Sciences Ltd Trimmed −1,977,079 −$22.3M 2.2%
Cidara Therapeutics Inc New +266,774 +$13M 4.2%
Revolution Medicines Inc Exited −318,782 −$11.3M —
Nuvalent Inc Trimmed −130,573 −$9.96M 1.5%
Legend Biotech Corp New +270,144 +$9.59M 3.1%
Xenon Pharmaceuticals Inc Exited −274,633 −$9.21M —
Rhythm Pharmaceuticals Inc Added +142,936 +$9.03M 3.6%
Centessa Pharmaceuticals PLC Added +672,337 +$8.83M 5.3%
Mineralys Therapeutics Inc New +631,586 +$8.55M 2.7%
Geron Corp Added +5,688,937 +$8.02M 3.0%

Showing the 10 largest of 81 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
Arcellx Inc New +273,774 +$18M 5.7%
CP Crinetics Pharmaceuticals In Exited −317,060 −$16.2M —
Syndax Pharmaceuticals Inc Trimmed −1,274,007 −$15.7M 6.3%
Madrigal Pharmaceuticals Inc New +40,936 +$13.6M 4.3%
Incyte Corp Exited −193,623 −$13.4M —
SR Scholar Rock Hldg Corp Added +399,905 +$12.9M 5.8%
Merus N V Trimmed −268,056 −$11.3M 4.7%
PP Praxis Precision Medicines I Exited −134,178 −$10.3M —
Bristol-myers Squibb Co Exited −166,068 −$9.39M —
Rhythm Pharmaceuticals Inc Trimmed −174,200 −$9.23M 0.6%

Showing the 10 largest of 84 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Arcutis Biotherapeutics Inc Trimmed −1,277,352 −$17.8M 1.7%
Amicus Therapeutics Inc Exited −1,481,809 −$15.8M —
Syndax Pharmaceuticals Inc Added +1,141,410 +$15.1M 9.5%
Xenon Pharmaceuticals Inc New +375,845 +$14.7M 3.7%
Applied Therapeutics Inc Exited −1,554,586 −$13.2M —
Nuvalent Inc New +145,234 +$11.4M 2.8%
Immunovant Inc Added +447,507 +$11.1M 6.9%
Alkermes PLC Added +368,050 +$10.6M 3.0%
Autolus Therapeutics PLC Exited −2,616,602 −$9.5M —
Centessa Pharmaceuticals PLC Added +558,302 +$9.35M 2.7%

Showing the 10 largest of 79 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support